Nov 27 (Reuters) - UK speciality pharmaceuticals company ProStrakan Group Plc on Thursday said it gave an exclusive license to Bayer Schering Pharma to develop and market its testosterone replacement ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results